Genetic, Microenvironmental, and Immunological Factors in Unresectable Pancreatic Ductal Adenocarcinoma
NCT ID: NCT05248750
Last Updated: 2024-02-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
250 participants
OBSERVATIONAL
2021-07-22
2026-07-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pancreatic Cancer Molecular Sub-classification Using Endoscopic Ultrasound Tissue Core Biopsy Samples
NCT04246710
A New Prognostic Score Model for Pancreatic Ductal Adenocarcinoma
NCT05547074
Early Recurrence After Surgery for Pancreatic Cancer
NCT07241676
Microbiota and Metabolites Alterations in Pancreatic Head and Body/Tail Cancer Patients
NCT06147154
Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer
NCT03977233
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Availability of biopsies obtained during EUS-FNB
* Histological diagnosis of pancreatic ductal adenocarcinoma of any stage
* Patients must be fit for chemotherapy administration
* They have to express their willingness to be followed up at our pancreatic high volume centers
* Age \>18 and \<80 years
* Able to sign informed consent
Exclusion Criteria
* Pregnancy or lactation
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Catholic University of the Sacred Heart
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Guido Costamagna
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alberto Larghi, MD
Role: PRINCIPAL_INVESTIGATOR
Fondazione Policlinico Universitario Agostino Gemelli
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
"Agostino Gemelli" Hospital, Catholic University of Sacred Heart
Rome, Lazio, Italy
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Carolina Gualtieri
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
MD
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PDAC AIRC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.